UK markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
134.04+1.75 (+1.32%)
At close: 04:00PM EDT
133.98 -0.06 (-0.04%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 29.95B
Enterprise value 23.66B
Trailing P/E 2.37
Forward P/E 3.10
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.31
Price/book (mrq)1.79
Enterprise value/revenue 1.02
Enterprise value/EBITDA 1.28

Trading information

Stock price history

Beta (5Y monthly) -0.29
52-week change 3-41.32%
S&P500 52-week change 3-8.83%
52-week high 3464.00
52-week low 3117.08
50-day moving average 3150.14
200-day moving average 3210.67

Share statistics

Avg vol (3-month) 31.39M
Avg vol (10-day) 31.41M
Shares outstanding 5243.02M
Implied shares outstanding 6N/A
Float 889.12M
% held by insiders 162.87%
% held by institutions 116.10%
Shares short (30 May 2022) 42M
Short ratio (30 May 2022) 41.46
Short % of float (30 May 2022) 4N/A
Short % of shares outstanding (30 May 2022) 40.82%
Shares short (prior month 28 Apr 2022) 42.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 Jun 2022
Ex-dividend date 401 Jun 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 55.20%
Operating margin (ttm)75.98%

Management effectiveness

Return on assets (ttm)90.32%
Return on equity (ttm)139.59%

Income statement

Revenue (ttm)23.3B
Revenue per share (ttm)95.37
Quarterly revenue growth (yoy)211.20%
Gross profit (ttm)16.07B
Net income avi to common (ttm)12.86B
Diluted EPS (ttm)55.75
Quarterly earnings growth (yoy)227.90%

Balance sheet

Total cash (mrq)6.17B
Total cash per share (mrq)25.37
Total debt (mrq)186M
Total debt/equity (mrq)1.17
Current ratio (mrq)5.05
Book value per share (mrq)65.47

Cash flow statement

Operating cash flow (ttm)5.25B
Levered free cash flow (ttm)2.93B